The Year in Cardio-oncology 2022-Reference-Cited by-同舟云学术

The Year in Cardio-oncology 2022

Published:2023-01 Issue:1 Volume:48 Page:101435
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Ahmed Talha^ORCID,Marmagkiolis Konstantinos,Ploch Michelle,Irizarry-Caro Jorge A.,Amatullah Atia,Desai Shyam,Aziz Moez K.,Yarrabothula Akshitha,Fossas-Espinosa José,Koutroumpakis Efstratios,Hassan Saamir,Karimzad Kaveh,Kim Peter,Cilingiroglu Mehmet,Iliescu Cezar

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference51 articles.

1. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

2. Adverse Cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy;Goldman;J Am Coll Cardiol,2021

3. Cardiotoxic effect of modern anthracycline dosing on left ventricular ejection fraction: A systematic review and meta-analysis of placebo arms from randomized controlled trials;Jeyaprakash;J Am Heart Assoc,2021

4. Clinical, echocardiographic, and biomarker associations with impaired cardiorespiratory fitness early after HER2-targeted breast cancer therapy;Bonsignore;JACC CardioOncol,2021

5. PRONOUNCE study investigators. Cardiovascular safety of degarelix versus leuprolide in patients with prostate cancer: the primary results of the PRONOUNCE randomized trial;Lopes;Circulation,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism;Biomedicine & Pharmacotherapy;2024-07

2. Cardiac Dysfunction and Arterial Hypertension as Manifestations of Cardiovasculotoxicity of iVEGF-Containing Chemotherapy. Clinical Case;Kardiologiia;2024-05-31

3. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management;Cardio-Oncology;2023-12-12

4. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway;Frontiers in Pharmacology;2023-02-09

5. Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost;International Journal of Molecular Sciences;2022-11-15